Karen Keeley

Karen Keeley has a diverse work experience in the field of business development and partnerships in the healthcare and clinical research industry. Karen has held senior roles in various organizations, including Emmes, where they served as the Senior Director of Business Development. In this role, they focused on advancing public health and biopharmaceutical innovation through collaborative relationships. Before that, they worked at the Decentralized Trials & Research Alliance (DTRA) as part of the DCT Initiative, which aimed to accelerate the adoption of patient-focused decentralized clinical trials and research.

Karen also worked at Medocity, Inc., as the Executive Director of Business Development and Partnerships for Digital Clinical Trial solutions. Here, they played a key role in developing sales strategies, identifying new pharma collaborations, and managing alliances to ensure client satisfaction. Prior to that, they had a role at Cognizant as the Digital Business Operations Sales Lead in the Life Sciences division.

Karen's experience also includes serving as a Senior Business Development Director at Covance, where they focused on clinical trial sales in all disease states and managed the full life cycle of global clinical trial sales. Karen has also held strategic business development roles in companies like Precision For Medicine and Agility Clinical CRO.

Additionally, Karen has participated in various committees and initiatives related to healthcare and blockchain technology, including the United Nations and Blockchain Commission for Sustainable Development.

Karen Keeley received their Master of Arts (M.A.) degree in Psychology, specializing in Human Behavior and Marketing, from National University between 1996 and 1998.